Evonik is one of the world's leading specialty chemicals companies. Profitable growth and sustained value creation form the heart of our strategy. Around 80 percent of sales come from leading market positions, which we plan to expand further. We concentrate on high-growth megatrends, especially health, nutrition, resource efficiency and globalization.
In 2016 Evonik’s more than 35,000 employees generated sales of Euro 12.7 billion and an operating result (adjusted EBITDA) of Euro 2.165 billion. Around 91 percent of sales are generated outside Germany, providing convincing evidence that our business is global.
2014.08~2015.05 Rocket Project； Work Scope: DED